Physician profile
Anthony L Ortegon
NPI 1356550354
$105,677.87
in general payments reported to CMS, 2019-2025
9 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $95.82 · 2021: $40.14 · 2022: $1,085 · 2023: $53K · 2024: $41K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $89K · Travel and Lodging: $7,240 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,300 · Food and Beverage: $3,973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $88,500.00 |
| Travel and Lodging | $7,239.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,300.00 |
| Food and Beverage | $3,972.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $104,963.08 | 2022-2025 | Da Vinci Surgical System |
| Philips North America LLC | $334.26 | 2019-2020 | |
| Veran Medical Technologies, INC. | $185.99 | 2019-2020 | |
| Glaxosmithkline, LLC. | $109.17 | 2021-2025 | Trelegy Ellipta, Nucala |
| Amgen INC. | $23.31 | 2025 | Tavneos |
| Genentech USA, INC. | $20.19 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.61 | 2021 | |
| Inspire Medical Systems, INC. | $13.77 | 2025 | Inspire |
| Electromed, INC. | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Ortegon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.